Brokaw cancer is treatable, but not curable

By Dr. Matthew Watson

Related Content

DAYTON, Ohio (WDTN) Longtime NBC News anchor Tom Brokaw announced Tuesday that he has cancer, but doctors say his chances of beating it are good.

Brokaw has multiple myeloma, a cancer affecting blood cells in the bone marrow.

A cancer or leukemia starts with the white cell count called plasma cells overpopulating. It can cause destruction of the bone, said Dr. Burhan Yanes, Miami Valley Hospital.

Normally, healthy bone would show solid in an x-ray. A bone damaged by multiple myeloma is spongy, with holes.

Then they could break. Thats the problem, you can break a bone, break your back and be paralyzed.

The disorder can also cause severe anemia and kidney damage.

There is no cure, but treatment, Dr. Yanes says, can extend life for a decade or more.

The standard treatment for anyone younger, less than age 65, we do chemo induction and after that we do high dose chemo and stem cell transplant.

The aggressive transplant for an older person like the 74 year old Tom Brokaw is risky.

See more here:
Brokaw cancer is treatable, but not curable

Related Post


categoriaBone Marrow Stem Cells commentoComments Off on Brokaw cancer is treatable, but not curable | dataFebruary 13th, 2014

About...

This author published 5872 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024